Smoking and COVID-19: Did we overlook representativeness?
作者信息
Wenzl Thomas
机构信息
European Commission, Joint Research Centre (JRC), Geel, Belgium.
出版信息
Tob Induc Dis. 2020 Nov 2;18:89. doi: 10.18332/tid/129584. eCollection 2020.
Abstract
摘要
相似文献
1
Smoking and COVID-19: Did we overlook representativeness?
Tob Induc Dis. 2020 Nov 2;18:89. doi: 10.18332/tid/129584. eCollection 2020.
2
Nicotine and smoking in the COVID-19 era.
J Cardiovasc Thorac Res. 2020;12(2):136-139. doi: 10.34172/jcvtr.2020.22. Epub 2020 May 28.
3
Let's not overlook nicotine.
J Anal Toxicol. 1996 Mar-Apr;20(2):143. doi: 10.1093/jat/20.2.143.
4
Nicotine and apoptosis.
Apoptosis. 2007 Nov;12(11):1927-43. doi: 10.1007/s10495-007-0102-8.
5
A population survey on legislative measures to restrict smoking in Ontario: 1. Design, methodology, and sample representativeness.
Am J Prev Med. 1986 Nov-Dec;2(6):307-15.
6
Nicotine treatment and smoking cessation in the era of COVID-19 pandemic: an interesting alliance.
ERJ Open Res. 2020 Aug 11;6(3). doi: 10.1183/23120541.00306-2020. eCollection 2020 Jul.
7
Managing long covid: don't overlook olfactory dysfunction.
BMJ. 2020 Sep 30;370:m3771. doi: 10.1136/bmj.m3771.
8
Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic.
Eur Cardiol. 2020 Apr 23;15:e16. doi: 10.15420/ecr.2020.11. eCollection 2020 Feb.
9
Nicotine level as a predictor of smoking frequency: a case report.
Int J Addict. 1984 Dec;19(8):827-32. doi: 10.3109/10826088409061988.
10
Transdermal nicotine replacement and smoking cessation.
Am Fam Physician. 1992 Jun;45(6):2595-602.
引用本文的文献
1
Case-control study of behavioural and societal risk factors for sporadic SARS-CoV-2 infections, Germany, 2020-2021 (CoViRiS study).
Epidemiol Infect. 2024 Jan 15;152:e16. doi: 10.1017/S0950268824000050.
2
Recognizing risk factors associated with poor outcomes among patients with COVID-19.
Prog Cardiovasc Dis. 2023 Jan-Feb;76:3-11. doi: 10.1016/j.pcad.2023.01.006. Epub 2023 Jan 21.
3
Nicotine has no significant cytoprotective activity against SARS-CoV-2 infection.
PLoS One. 2022 Aug 18;17(8):e0272941. doi: 10.1371/journal.pone.0272941. eCollection 2022.
4
Differences in Clinical Outcomes between Smokers and Non-Smokers infected with COVID-19.
Arch Razi Inst. 2022 Feb 28;77(1):449-459. doi: 10.22092/ARI.2021.356682.1894. eCollection 2022 Feb.
5
SARS-Co-V2 infection in never, former, and current tobacco/nicotine users: a cohort study of 4040 Egyptian healthcare workers.
BMC Public Health. 2021 Jun 28;21(1):1243. doi: 10.1186/s12889-021-11290-x.
6
Perceived health risks associated with the use of tobacco and nicotine products during the COVID-19 pandemic.
Tob Induc Dis. 2021 Jun 9;19:46. doi: 10.18332/tid/136040. eCollection 2021.
7
ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19.
J Clin Epidemiol. 2021 Nov;139:240-254. doi: 10.1016/j.jclinepi.2021.06.005. Epub 2021 Jun 11.
8
Cigarette and E-Cigarettes Dual Users, Exclusive Users and COVID-19: Findings from Four UK Birth Cohort Studies.
Int J Environ Res Public Health. 2021 Apr 8;18(8):3935. doi: 10.3390/ijerph18083935.
9
Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.
Genome Med. 2021 Apr 21;13(1):66. doi: 10.1186/s13073-021-00866-2.
10
Response to the Comment on "A Systematic Review and Meta-Analysis of Hospitalised Current Smokers and COVID-19".
Int J Environ Res Public Health. 2020 Dec 21;17(24):9574. doi: 10.3390/ijerph17249574.
本文引用的文献
1
The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7).
Addiction. 2021 Jun;116(6):1319-1368. doi: 10.1111/add.15276. Epub 2020 Nov 17.
2
Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm.
Front Immunol. 2020 Jun 11;11:1359. doi: 10.3389/fimmu.2020.01359. eCollection 2020.
3
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00688-2020. Print 2020 May.
4
Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).
J Clin Med. 2020 Mar 20;9(3):841. doi: 10.3390/jcm9030841.
Zotero 插件